236 related articles for article (PubMed ID: 18827195)
1. Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.
Hernández-Pando R; Aguilar D; Orozco H; Cortez Y; Brunet LR; Rook GA
Clin Vaccine Immunol; 2008 Nov; 15(11):1730-6. PubMed ID: 18827195
[TBL] [Abstract][Full Text] [Related]
2. Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model.
Hunt JR; Martinelli R; Adams VC; Rook GA; Brunet LR
Clin Exp Allergy; 2005 May; 35(5):685-90. PubMed ID: 15898994
[TBL] [Abstract][Full Text] [Related]
3. Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TB.
Dlugovitzky D; Stanford C; Stanford J
Immunotherapy; 2011 Apr; 3(4):557-68. PubMed ID: 21463195
[TBL] [Abstract][Full Text] [Related]
4. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
[TBL] [Abstract][Full Text] [Related]
7. GLS/IL-12-modified Mycobacterium smegmatis as a novel anti-tuberculosis immunotherapeutic vaccine.
Yang C; He YL; Zhang L; Xu L; Yi Z; Wang Y; Li N; Zhu D
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1360-6. PubMed ID: 19861007
[TBL] [Abstract][Full Text] [Related]
8. [Effects of vaccae on airway inflammation and Th1/Th2 cytokines in sensitized mice].
Xie Q; Bian R; Wu K; Zheng X
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Aug; 25(8):488-92. PubMed ID: 12425837
[TBL] [Abstract][Full Text] [Related]
9. [Mycobacterium vaccae influences the kinetics of Th1/Th2 cells and expression of iNOS in a marine model of experimental tuberculosis].
Zhang L; Ma W; Da J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):43-6. PubMed ID: 11778182
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy.
Zárate-Bladés CR; Bonato VL; da Silveira EL; Oliveira e Paula M; Junta CM; Sandrin-Garcia P; Fachin AL; Mello SS; Cardoso RS; Galetti FC; Coelho-Castelo AA; Ramos SG; Donadi EA; Sakamoto-Hojo ET; Passos GA; Silva CL
J Gene Med; 2009 Jan; 11(1):66-78. PubMed ID: 19035575
[TBL] [Abstract][Full Text] [Related]
11. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
Luo Y;
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):43-7. PubMed ID: 11802939
[TBL] [Abstract][Full Text] [Related]
12. Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice.
Hernandez-Pando R; Pavon L; Orozco EH; Rangel J; Rook GA
Immunology; 2000 Jul; 100(3):391-8. PubMed ID: 10929063
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutical potential of Mycobacterium vaccae on M. tuberculosis infection in mice.
Xu LJ; Wang YY; Zheng XD; Gui XD; Tao LF; Wei HM
Cell Mol Immunol; 2009 Feb; 6(1):67-72. PubMed ID: 19254482
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
Huang CY; Hsieh WY
Hum Vaccin Immunother; 2017 Sep; 13(9):1960-1971. PubMed ID: 28604170
[TBL] [Abstract][Full Text] [Related]
15. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.
Liang Y; Wu X; Zhang J; Yang Y; Wang L; Bai X; Yu Q; Li N; Li Z
Scand J Immunol; 2011 Jul; 74(1):42-6. PubMed ID: 21352251
[TBL] [Abstract][Full Text] [Related]
16. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].
Bai YL; Xue Y; Wang LM; Fan AL; Zhang W; Kang J; He JJ; Xu ZK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar; 25(3):211-4. PubMed ID: 19257983
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for tuberculosis: what's the better choice?
Guo S; Zhao J
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2684-90. PubMed ID: 22652806
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with oral, heat-killed, Mycobacterium vaccae in patients with moderate to advanced pulmonary tuberculosis.
Dlugovitzky D; Notario R; Martinel-Lamas D; Fiorenza G; Farroni M; Bogue C; Stanford C; Stanford J
Immunotherapy; 2010 Mar; 2(2):159-69. PubMed ID: 20635925
[TBL] [Abstract][Full Text] [Related]
19. Long-term modulatory effect of Mycobacterium vaccae treatment on histopathologic changes in a murine model of asthma.
Yazi D; Akkoc T; Ozdemir C; Yesil O; Aydogan M; Sancak R; Bahceciler NN; Barlan IB
Ann Allergy Asthma Immunol; 2007 Jun; 98(6):573-9. PubMed ID: 17601272
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice.
Adams VC; Hunt JRF; Martinelli R; Palmer R; Rook GAW; Brunet LR
Eur J Immunol; 2004 Mar; 34(3):631-638. PubMed ID: 14991592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
